Odense C

• Senolytics to Improve Osteoporosis therapy: A randomised controlled clinical trial The SENIOR Trial Not authorised
  2022-500669-28-00 4 Osteoporosis
• An European multinational study of a personalized approach of human albumin administration in patients with cirrhosis of the liver and compl … Not authorised
  2022-501006-34-00 5 Liver cirrhosis
• A study to investigate long-term safety and tolerability of tolebrutinib in participants with multiple sclerosis Not authorised
  2023-503631-18-00 5 Nervous system diseases
• Safety and efficacy of oral semaglutide in hyperglycaemic patients after renal transplantation Not authorised
  2023-504159-29-00 4 Hyperglycaemia after renal transplantation
• Phase 1b/2a Study to Evaluate Alnuctamab in Combination with Mezigdomide in Relapsed and/or Refractory Multiple Myeloma. Not authorised
  2023-504367-16-00 4 Relapsed and/or Refractory Multiple Myeloma
• Safety, tolerability, and efficacy of mFOLFIRINOX ±BNT321 as adjuvant therapy following curative resection in patients with pancreatic adeno … Not authorised
  2023-506014-47-00 9 Resected (R0 or R1) pancreatic ductal adenocarcinoma
• Epinephrine versus Isoprenaline During Out-of-Hospital Cardiac Arrest with Non-Shockable Rhytm (EPISO) Not authorised
  2024-516074-29-00 5 Cardiac arrest
• IntReALL BCP 2020 – International Study for Treatment of Childhood Relapsed Precursor B-cell ALL 2020 Pending
  2023-509392-17-00 5 Relapsed Acute Lymphoblastic Leukemia (ALL)
• Repurposing Everolimus to enhance musculoskeletal Vitality and Ageing in The Elderly (RENOVATE) Pending
  2023-509838-19-00 4 General healthy elderly with stable medical conditions
• Use of Isoprenaline with Epinephrine During Out-of-Hospital Cardiac Arrest with Non-Shockable Rhytm (EPISO) Pending
  2024-516074-29-01 5 Cardiac arrest
• A multicenter, randomized, open-label, blinded-assessor, phase 4 study in patients with early rheumatoid arthritis to compare active convent … Pending
  2024-516723-14-00 6 Rheumatoid Arthritis
• Comparison of neurocognitive outcome in two standard regimen for treatment of low-risk medulloblastoma (COGNITO-MB) Pending
  2024-517133-40-00 5 newly diagnosed, non-metastatic, SHH-activated, TP53-wt, non-MYC ampli
• Efficacy, safety, and tolerability study of lunsekimig compared with placebo in adult participants with inadequately controlled chronic obst … Pending
  2024-518016-39-00 10 Respiratory tract diseases
• Study to Investigate the Efficacy, Safety, and Tolerability of Intravenous Gammagard Liquid (Immune Globulin Infusion, 10%) for Primary Infe … Pending
  2024-518420-80-00 5 Primary infection prophylaxis for secondary immunodeficiency (SID) in
• TRALULALA-AZI Pending
  2024-518730-88-00 6 Chronic Atelectasis
• The SGL-TX-PTDM study Pending
  2024-518774-14-00 4 Kidney transplant recipients
• Dose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults with Non-cystic Fibrosis Bronchiectasis (NCFB) Pending
  2024-518821-13-00 4 Non-cystic Fibrosis Bronchiectasis
• BEAT Fatigue Pending
  2024-519268-41-00 6 Fatigue in rheumatoid arthritis patients
• Aciclovir for HSV-2 MENingitis: A double-blinded randomised controlled trial (AMEN) Pending
  2024-520042-31-00 6 HSV-2 meningitis
• The MAYA2 trial Pending
  2025-521941-25-00 4 Colorectal cancer
• A Study Testing the Investigational Drug XmAb541 in people with Advanced Cancer Pending
  2025-521981-90-00 1 Advanced Solid Tumors
• A Phase II, Open-label, Multicenter Study Testing Teclistamab in Combination with Pomalidomide Administered in Alternative Fashion in Partic … Pending
  2025-522114-23-00 4 Multiple myeloma (RRMM)
• A Study to Evaluate the Long-term Safety and Tolerability of Admilparant in Participants with Pulmonary Fibrosis. Pending
  2025-522373-10-00 5 Progressive pulmonary fibrosis and Idiopathic pulmonary fibrosis
• Osteogenesis Imperfecta Trial of AGA2115 for ADUlts with COL1A1 and/or COL1A2 GeNetic Variations (IDUN) Pending
  2025-522951-24-00 4 Osteogenesis Imperfecta

Showing 1–24 of 467 trials